Transcranial Magnetic Stimulation in Child and Adolescent Psychiatric Disorders.
- Author:
Myung Ho LIM
1
;
Ki Chung PAIK
;
Jeong Ho CHAE
Author Information
1. Department of Psychiatry, College of Medicine, Dankook University, Cheonan, Korea. paperose@dku.edu
- Publication Type:Review
- Keywords:
Child and adolescent psychiatric disorder;
TMS (transcranial magnetic stimulation);
rTMS (repeated transcranial magnetic stimulation)
- MeSH:
Adolescent;
Adult;
Child;
Depressive Disorder, Major;
Humans;
Imidazoles;
Nitro Compounds;
Transcranial Magnetic Stimulation;
United States Food and Drug Administration
- From:Korean Journal of Psychopharmacology
2009;20(1):15-21
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Repeated transcranial magnetic stimulation (rTMS) is a noninvasive treatment method recently approved by the U.S. Food and Drug Administration for the treatment of major depressive disorder in adults. Few clinical experiences with TMS or rTMS have been reported in children and adolescents. The clinical application of rTMS in children and adolescents should rest on data showing clinical efficacy and age-related safety. Despite these cautions, rTMS offers the advantage of noninvasive treatment and represents an alternative to classical drug treatment. We reviewed the effect of TMS and rTMS in child and adolescent psychiatric disorders.
